You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oxaliplatin

Showing 51 - 75 of 922
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Extranodal NK/T-cell Lymphoma Trial (Sugemalimab, Placebo, Pegaspargase)

Not yet recruiting
  • Extranodal NK/T-cell Lymphoma
  • Sugemalimab
  • +4 more
  • (no location specified)
Jan 17, 2023

Rectal Cancer, Consolidation Trial in São Paulo (Oxaliplatin, 5FU)

Recruiting
  • Rectal Cancer
  • Consolidation
  • São Paulo, SP, Brazil
    Hospital Alemão Oswaldo Cruz
Aug 3, 2021

GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)

Active, not recruiting
Has Results
  • GastroEsophageal Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 7, 2022

Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)

Recruiting
  • Rectal Neoplasms
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Aug 27, 2023

Biliary Tract Tumors, Cholangiocarcinoma, Bile Duct Cancer Trial run by the NCI (Pembrolizumab (MK-3475), Oxaliplatin,

Completed
Has Results
  • Biliary Tract Neoplasms
  • +4 more
  • Pembrolizumab (MK-3475)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 1, 2021

Gastric Cancer, GastroEsophageal Cancer Trial in Beijing (SHR-1210, Capecitabine, Oxaliplatin)

Active, not recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital, Peking University
Aug 24, 2021

Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)

Not yet recruiting
  • Advanced Solid Tumor
  • JS015
  • +10 more
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 17, 2023

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Esophagus Cancer Trial in United States (Oxaliplatin, Docetaxel, Capecitabine)

Completed
Has Results
  • Esophagus Cancer
  • Oxaliplatin
  • +3 more
  • Beverly Hills, California
  • +6 more
Oct 29, 2021

Colon Tumor Trial in Hangzhou (Oxaliplatin, Capecitabine, Anti-PD-L1 Monoclonal Antibody)

Not yet recruiting
  • Colon Neoplasm
  • Oxaliplatin
  • +4 more
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital of Zhejiang University School of Medi
Jun 25, 2023

Colorectal Cancer, Metastatic Cancer Trial in New Brunswick, New York (FOLFOX regimen, dexamethasone, floxuridine)

Active, not recruiting
  • Colorectal Cancer
  • Metastatic Cancer
  • FOLFOX regimen
  • +7 more
  • New Brunswick, New Jersey
  • +1 more
Jul 1, 2022

Colorectal Cancer Metastatic Trial in Vejle (drug, dietary supplement, other)

Recruiting
  • Colorectal Cancer Metastatic
  • Vejle, Denmark
    Department of Oncology, Vejle Hospital
Nov 17, 2022

Breast Cancer Trial in United States (Trastuzumab, Oxaliplatin)

Completed
Has Results
  • Breast Cancer
  • Bowling Green, Kentucky
  • +6 more
Oct 13, 2021

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

Not yet recruiting
  • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jul 17, 2023

Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Netherlands (Capecitabine, Oxaliplatin, Retifanlimab)

Recruiting
  • Gastric Adenocarcinoma
  • Esophageal Adenocarcinoma
  • Amsterdam, Netherlands
  • +7 more
Jan 31, 2022

Gastric Cancer Trial in Shanghai (PLD, Oxaliplatin, Capecitabine)

Recruiting
  • Gastric Cancer
  • Shanghai, China
    Shanghai General Hospital
Sep 7, 2022

Rectal Tumors Trial in Guangzhou (Oxaliplatin, capecitabine, Radiation)

Active, not recruiting
  • Rectal Neoplasms
  • Oxaliplatin
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University, Cancer Center
Jul 26, 2022

Colorectal Cancer Stage II, Colorectal Cancer Stage III, Mmr Deficiency Trial in Guangzhou (drug, radiation, procedure, other)

Active, not recruiting
  • Colorectal Cancer Stage II
  • Colorectal Cancer Stage III
  • Oxaliplatin
  • +5 more
  • Guangzhou, Guangdong, China
    Medical Oncology,Sun Yat-sen University Cancer Center
Jan 29, 2023

pMMR, MSS, MSI-L Trial (Serplilumab, Capecitabine, Oxaliplatin)

Not yet recruiting
  • pMMR
  • +3 more
  • (no location specified)
Feb 19, 2023

Low Rectal Cancer Trial in Hanzhou (Modified short-course radiotherapy, PD-1 antibody, Capecitabine)

Not yet recruiting
  • Low Rectal Cancer
  • Modified short-course radiotherapy
  • +3 more
  • Hanzhou, Zhejiang, China
    Sir Run Run Shao hospital
Jul 31, 2023

Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced
  • +3 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital Southern Medical University
May 17, 2023

Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)

Recruiting
  • Pancreatic Cancer
  • Sydney, New South Wales, Australia
  • +2 more
Oct 19, 2023

Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,

Recruiting
  • Metastatic Gastric Cancer
  • +2 more
  • New York, New York
    Bureau for Cancer Research
May 10, 2023

Platinum-Sensitive Biliary Tract Cancer Trial (Cisplatin, Gemcitabine, Oxaliplatin)

Withdrawn
  • Platinum-Sensitive Biliary Tract Cancer
  • (no location specified)
May 27, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022